A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease

This study has been completed.
Sponsor:
Collaborators:
Cato Research
ClinPharm Consulting, LLC
Infrared Imaging and Thermometry Unit, Biomedical Engineering and Physical Science Shared Resource (NIBIB)
National Chung Cheng University
QS Pharma
Ricerca Biosciences LLC
SAIC-Frederick, Inc.
Information provided by (Responsible Party):
AesRx, LLC
ClinicalTrials.gov Identifier:
NCT01597401
First received: April 26, 2012
Last updated: July 1, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)